Skip to main content

Table 3 Kaplan-Meier analysis of integument-related toxicities

From: Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

 

Median (95% CI)

WT KRAS

MT KRAS

Overall

(n = 86)

(n = 59)

(n = 154)

Time to first integument toxicity, days [min, max]

  Any grade

8.0 (7,0, 10.0)

10.0 (7.0, 13.0)

8.0 (7.0, 11.0)

[0, 155]

[0, 125]

[0, 155]

  Grade ≥3

NE (300.0, NE)

NE (175.0, NE)

408.0 (300.0, NE)

 

[6, 528]

[0, 389]

[0, 528]

Duration of integument toxicity, days [min, max]

  Any grade

452.0 (244.0, NE)

321.0 (228.0, 371.0)

334.0 (244.0, NE)

[14, 492]

[19, 445]

[14, 492]

  Grade ≥3

32.0 (17.0, 43.0)

55.5 (25.0, 80.0)

36.0 (25.0, 54.0)

 

[5, 322]

[5, 268]

[5, 322]

Time to resolution, days [min, max]

  Any grade

103.0 (55.0, NE)

71.0 (52.0, 86.0)

71.0 (59.0, 162.0)

[0, 309]

[5, 162]

[0, 309]

  Grade ≥3

103.0 (68.0, NE)

86.0 (86.0, 162.0)

86.0 (68.0, 162.0)

 

[0, 124]

[12, 162]

[0, 162]

  1. NE not estimable.